Documents reveal thalidomide’s manufacturer was warned about possible harms as early as 1956.
Articles on Drug safety
Displaying 41 - 44 of 44 articles
Combination drugs are considered an innovation of India’s medicines industry but they are not as safe as they should be.
With the death of Nigeria’s Dora Akunyili, a passionate campaigner against falsified and substandard medicines, the fight against fake drugs in Africa just got more difficult. Akunyili was director-general…
In 2001 I met David Graham, an official from the US Food and Drug Administration, in a car park in Washington. I wanted him to shed light on why the diabetes drug troglitazone, or Rezulin, had been available…
Top contributors
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Reader in Clinical Pharmacology and Medical Education, Queen Mary University of London
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
Senior Research Fellow, University of Oxford
-
Associate Professor in Mechanical Engineering, Texas A&M University
-
Doctoral Student in Biochemistry, University of Washington
-
Professor in Developmental Biology, University of Aberdeen
-
Emeritus Professor of Clinical Sciences, University of Bristol
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Associate Professor in Pharmacy Practice and Digital Public Health, Kingston University
-
Research Fellow in African Studies, University of Edinburgh